Clinical Trial Update: A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating HIP0612 for gastric ulcer has completed; the update does not provide study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• HIP0612

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Gastric Ulcer | Phase 3 | Status: COMPLETED